$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hepatobiliary
Hepatobiliary
司拉德帕的适应症
2025-10-19 11:44:20
Check Details
司拉德帕的用法用量
2025-10-19 11:44:20
Check Details
埃拉菲布拉诺(elafibranor)FDA获批用于治疗原发性胆汁性胆管炎
2025-10-19 11:44:20
Check Details
埃拉菲布拉诺(elafibranor)用法用量:推荐剂量、特殊人群剂量调整
2025-10-19 11:44:20
Check Details
埃拉菲布拉诺(elafibranor)的副作用和常见不良反应
2025-10-19 11:44:20
Check Details
埃拉菲布拉诺(elafibranor)详细说明书
2025-10-19 11:44:20
Check Details
埃拉菲布拉诺(elafibranor)中文说明书:适应症、用法用量、不良反应、注意事项、特殊人群用药
2025-10-19 11:44:20
Check Details
瑞司美替罗治疗非酒精性肝炎伴有肝纤维化的效果怎么样?
2025-10-19 11:44:20
Check Details
非酒精性脂肪性肝炎治疗药物瑞司美替罗的作用功效?
2025-10-19 11:44:20
Check Details
瑞司美替罗(Rezdiffra)的功效与作用及注意事项
2025-10-19 11:44:20
Check Details
瑞司美替罗(Rezdiffra)显著降低脂肪肝水平
2025-10-19 11:44:20
Check Details
瑞司美替罗的用药剂量调整详细说明
2025-10-19 11:44:20
Check Details
1
2
...
497
498
499
500
501
502
503
504
505
506
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Odevixibat: Targeting IBAT to Transform Cholestatic Liver Disease Treatment
2
A Precision FGFR Inhibitor for Cholangiocarcinoma
3
Best time to take Luqu Bopa (Wenkedake) and precautions
4
Is defibrotide included in medical insurance?
5
When was defibrinoside launched on the market?
6
Will defibrination be reimbursed by medical insurance?
7
What conditions is defibrinoside suitable for treating?
8
What is the therapeutic effect of defibrotide?
9
How should defibrinoside be used?
10
What is the effect of defibrotide?
11
Defibrinoside Detailed Instructions
12
What is the effect of defibrination?